Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Expert Reviews in Molecular Medicine is Scopus-indexed (Q1, CiteScore 9.9), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme for reading access. Published by Cambridge University Press.
Checked against the index lists dated .
ISSN 1462-3994Verify ISSN ↗
Publisher: Cambridge University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Molecular Biology | 68 / 414 | 83rd | Q1 |
| Molecular Medicine | 34 / 179 | 81st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1997–present, best quartile Q1, CiteScore 9.9.
Expert Reviews in Molecular Medicine is Q1 in Molecular Biology (rank 68 of 414) and Q1 in Molecular Medicine (rank 34 of 179), by CiteScore 2025.
Expert Reviews in Molecular Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.9, which places it in quartile Q1 at the 83rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.686, quartile Q1, with an H-index of 99.
The publisher lists an article processing charge of about US$3,550 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Expert Reviews in Molecular Medicine is published by Cambridge University Press. Its ISSN is 1462-3994.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Expert Reviews in Molecular Medicine has an h-index of 112 and a 2-year mean of 7.14 citations per paper (OpenAlex). Its Scopus CiteScore is 9.9, quartile Q1. On 2-year citations it ranks #48 of 411 Scopus journals in Molecular Biology.
Expert Reviews in Molecular Medicine published 37 papers in 2025; its busiest recent year was 2022 with 48. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from China (35.5%), United Kingdom (9.6%) and Iran (8.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.